East and North Hertfordshire NHS Trust Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02055690
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

East and North Hertfordshire NHS Trust | East and North Herts NHS Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 2)

Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 2)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6